Del Re M - Search Results

1

Digital Droplet PCR in Hematologic Malignancies: A New Useful Molecular Tool.

Galimberti S, Balducci S, Guerrini F, Del Re M, Cacciola R. Galimberti S, et al. Among authors: del re m. Diagnostics (Basel). 2022 May 24;12(6):1305. doi: 10.3390/diagnostics12061305. Diagnostics (Basel). 2022. PMID: 35741115 Free PMC article. Review.

2

Real-Time PCR and Droplet Digital PCR: two techniques for detection of the JAK2(V617F) mutation in Philadelphia-negative chronic myeloproliferative neoplasms.

Fontanelli G, Baratè C, Ciabatti E, Guerrini F, Grassi S, Del Re M, Morganti R, Petrini I, Arici R, Barsotti S, Metelli MR, Danesi R, Galimberti S. Fontanelli G, et al. Among authors: del re m. Int J Lab Hematol. 2015 Dec;37(6):766-73. doi: 10.1111/ijlh.12404. Epub 2015 Jul 20. Int J Lab Hematol. 2015. PMID: 26189968

3

The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.

Guerrini F, Paolicchi M, Ghio F, Ciabatti E, Grassi S, Salehzadeh S, Ercolano G, Metelli MR, Del Re M, Iovino L, Petrini I, Carulli G, Cecconi N, Rousseau M, Cervetti G, Galimberti S. Guerrini F, et al. Among authors: del re m. Front Pharmacol. 2016 Oct 13;7:363. doi: 10.3389/fphar.2016.00363. eCollection 2016. Front Pharmacol. 2016. PMID: 27790140 Free PMC article.

4

Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment.

Arrigoni E, Del Re M, Galimberti S, Restante G, Rofi E, Crucitta S, Baratè C, Petrini M, Danesi R, Di Paolo A. Arrigoni E, et al. Among authors: del re m. Stem Cells Transl Med. 2018 Mar;7(3):305-314. doi: 10.1002/sctm.17-0175. Epub 2018 Feb 8. Stem Cells Transl Med. 2018. PMID: 29418079 Free PMC article. Review.

5

Pharmacology differences among proteasome inhibitors: Implications for their use in clinical practice.

Fogli S, Galimberti S, Gori V, Del Re M, Danesi R. Fogli S, et al. Among authors: del re m. Pharmacol Res. 2021 May;167:105537. doi: 10.1016/j.phrs.2021.105537. Epub 2021 Mar 6. Pharmacol Res. 2021. PMID: 33684510 Review.

6

Molecular analysis of cell-free circulating DNA for the diagnosis of somatic mutations associated with resistance to tyrosine kinase inhibitors in non-small-cell lung cancer.

Del Re M, Vasile E, Falcone A, Danesi R, Petrini I. Del Re M, et al. Expert Rev Mol Diagn. 2014 May;14(4):453-68. doi: 10.1586/14737159.2014.908120. Epub 2014 Apr 11. Expert Rev Mol Diagn. 2014. PMID: 24725257 Review.

7

The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies.

Attili I, Del Re M, Guerini-Rocco E, Crucitta S, Pisapia P, Pepe F, Barberis M, Troncone G, Danesi R, de Marinis F, Malapelle U, Passaro A. Attili I, et al. Among authors: del re m. Expert Rev Mol Diagn. 2021 Aug;21(8):757-766. doi: 10.1080/14737159.2021.1943365. Epub 2021 Jul 18. Expert Rev Mol Diagn. 2021. PMID: 34278933 Review.

8

Plasma Cell-Free DNA Testing of Patients With EGFR Mutant Non-Small-Cell Lung Cancer: Droplet Digital PCR Versus Next-Generation Sequencing Compared With Tissue-Based Results.

Steendam CMJ, Atmodimedjo P, de Jonge E, Paats MS, van der Leest C, Oomen-de Hoop E, Jansen MPHM, Del Re M, von der Thüsen JH, Dinjens WNM, van Schaik RHN, Aerts JGJV, Dubbink HJ; Erasmus MC Cancer Institute. Steendam CMJ, et al. Among authors: del re m. JCO Precis Oncol. 2019 Dec;3:1-9. doi: 10.1200/PO.18.00401. JCO Precis Oncol. 2019. PMID: 35100738

9

The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response.

Del Re M, Bordi P, Rofi E, Restante G, Valleggi S, Minari R, Crucitta S, Arrigoni E, Chella A, Morganti R, Tiseo M, Petrini I, Danesi R. Del Re M, et al. Br J Cancer. 2018 Nov;119(10):1252-1258. doi: 10.1038/s41416-018-0238-z. Epub 2018 Nov 6. Br J Cancer. 2018. PMID: 30397287 Free PMC article.

10

Comparison of variant allele frequency and number of mutant molecules as units of measurement for circulating tumor DNA.

Bos MK, Nasserinejad K, Jansen MPHM, Angus L, Atmodimedjo PN, de Jonge E, Dinjens WNM, van Schaik RHN, Del Re M, Dubbink HJ, Sleijfer S, Martens JWM. Bos MK, et al. Among authors: del re m. Mol Oncol. 2021 Jan;15(1):57-66. doi: 10.1002/1878-0261.12827. Epub 2020 Oct 31. Mol Oncol. 2021. PMID: 33070443 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page